Literature DB >> 23838029

Seizure susceptibility, phenotype, and resultant growth delay in the nclf and mnd mouse models of neuronal ceroid lipofuscinoses.

Elizabeth Kriscenski-Perry1, Attila D Kovács, David A Pearce.   

Abstract

We examined flurothyl gas-induced seizure latencies and phenotype in 2 mouse models of neuronal ceroid lipofuscinoses: the nclf (Cln6 mutant) variant late-infantile model and the mnd (Cln8 mutant) Northern epilepsy model. Mnd mice on postnatal days 35 to 42 had increased latency to loss of posture compared with wild-type controls. Nclf, mnd, and wild-type mice on postnatal days 21 days to 25 displayed similar latency profiles during repeated seizure induction (kindling) and retesting; seizure phenotypes were different, however. Kindled wild-type mice reexposed to flurothyl after a 28-day recovery displayed brainstem generalized seizures exclusively. Neuronal ceroid lipofuscinoses mutants demonstrated a lack of brainstem seizures at retesting after 28 days. Repeated induction of generalized seizures delayed weight gain in both nclf and mnd mice compared with wild-type mice. These and our previous results suggest that abnormal seizure-related neuronal connectivity and/or plasticity are shared characteristics of the neuronal ceroid lipofuscinoses.

Entities:  

Keywords:  Batten disease; epilepsy; flurothyl; neuronal ceroid lipofuscinoses; seizure induction latencies

Mesh:

Substances:

Year:  2013        PMID: 23838029      PMCID: PMC4078599          DOI: 10.1177/0883073813493667

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  19 in total

1.  Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease.

Authors:  Attila D Kovács; Angelika Saje; Andrew Wong; Gábor Szénási; Péter Kiricsi; Eva Szabó; Jonathan D Cooper; David A Pearce
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

2.  Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9.

Authors:  R T Bronson; L R Donahue; K R Johnson; A Tanner; P W Lane; J R Faust
Journal:  Am J Med Genet       Date:  1998-05-26

3.  The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.

Authors:  S Ranta; Y Zhang; B Ross; L Lonka; E Takkunen; A Messer; J Sharp; R Wheeler; K Kusumi; S Mole; W Liu; M B Soares; M F Bonaldo; A Hirvasniemi; A de la Chapelle; T C Gilliam; A E Lehesjoki
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

Review 4.  Seizures, depression and dementia in teenagers with Batten disease.

Authors:  R M Boustany; P Filipek
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 5.  Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms.

Authors:  Clare M Gladding; Stephen M Fitzjohn; Elek Molnár
Journal:  Pharmacol Rev       Date:  2009-11-19       Impact factor: 25.468

Review 6.  Neuronal ceroid lipofuscinoses.

Authors:  Anu Jalanko; Thomas Braulke
Journal:  Biochim Biophys Acta       Date:  2008-11-24

7.  Bidirectional transfer between electrical and flurothyl kindling in mice: evidence for common processes in epileptogenesis.

Authors:  R J Ferland; C D Applegate
Journal:  Epilepsia       Date:  1999-02       Impact factor: 5.864

8.  Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease.

Authors:  Attila D Kovács; David A Pearce
Journal:  Exp Neurol       Date:  2007-10-25       Impact factor: 5.330

Review 9.  The neuronal ceroid-lipofuscinoses.

Authors:  H H Goebel
Journal:  J Child Neurol       Date:  1995-11       Impact factor: 1.987

Review 10.  Regulation of AMPA receptor trafficking and synaptic plasticity.

Authors:  Victor Anggono; Richard L Huganir
Journal:  Curr Opin Neurobiol       Date:  2012-01-02       Impact factor: 6.627

View more
  1 in total

1.  A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease.

Authors:  Logan Langin; Tyler B Johnson; Attila D Kovács; David A Pearce; Jill M Weimer
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.